Defective VWF cleavage by ADAMTS13 variant
|
|
|
- ADAMTS13
- C9orf8
- F8VWF
- VWF
|
Homo sapiens (human)
|
|
Enhanced cleavage of VWF variant by ADAMTS13
|
|
|
- ADAMTS13
- C9orf8
- F8VWF
- VWF
|
Homo sapiens (human)
|
|
Defective VWF binding to collagen type I
|
|
|
|
Homo sapiens (human)
|
|
Assembly Of The HIV Virion
|
|
|
- CYPA
- PPIA
- RPS27A
- UBA52
- UBA80
- UBB
- UBC
- UBCEP1
- UBCEP2
- env
- gag
- gag-pol
- nef
- rev
- vif
- vpr
- vpu
|
Homo sapiens (human)
|
|
Synthesis and processing of ENV and VPU
|
|
|
- FUR
- FURIN
- PACE
- PCSK3
- env
- vpu
|
Homo sapiens (human)
|
|
Uncoating of the HIV Virion
|
|
|
- CYPA
- PPIA
- gag
- gag-pol
- nef
- rev
- vif
- vpr
- vpu
|
Homo sapiens (human)
|
|
Early Phase of HIV Life Cycle
|
|
|
- CYPA
- FEN1
- LIG1
- PPIA
- RAD2
- gag
- gag-pol
- rev
- vif
- vpr
- vpu
|
Homo sapiens (human)
|
|
Minus-strand DNA synthesis
|
|
|
- CYPA
- PPIA
- gag
- gag-pol
- rev
- vif
- vpr
- vpu
|
Homo sapiens (human)
|
|
Plus-strand DNA synthesis
|
|
|
- CYPA
- PPIA
- gag
- gag-pol
- rev
- vif
- vpr
- vpu
|
Homo sapiens (human)
|
|
Synthesis And Processing Of GAG, GAGPOL Polyproteins
|
|
|
|
Homo sapiens (human)
|
|
Nef and signal transduction
|
|
|
- DOCK2
- ELMO1
- FYN
- HCK
- KIAA0209
- KIAA0281
- LCK
- PAK2
- RAC1
- TC25
- nef
|
Homo sapiens (human)
|
|
Nef mediated downregulation of CD28 cell surface expression
|
|
|
- AP2M1
- CD28
- CLAPM1
- KIAA0109
- nef
|
Homo sapiens (human)
|
|
Late Phase of HIV Life Cycle
|
|
|
|
Homo sapiens (human)
|
|
Resistance of ERBB2 KD mutants to lapatinib
|
|
|
- CDC37
- CDC37A
- ERBB2
- ERBB2IP
- ERBIN
- HER2
- HSP90A
- HSP90AA1
- HSPC1
- HSPCA
- KIAA1225
- LAP2
- MLN19
- NEU
- NGL
|
Homo sapiens (human)
|
|
Resistance of ERBB2 KD mutants to sapitinib
|
|
|
- CDC37
- CDC37A
- ERBB2
- ERBB2IP
- ERBIN
- HER2
- HSP90A
- HSP90AA1
- HSPC1
- HSPCA
- KIAA1225
- LAP2
- MLN19
- NEU
- NGL
|
Homo sapiens (human)
|
|
Resistance of ERBB2 KD mutants to AEE788
|
|
|
- CDC37
- CDC37A
- ERBB2
- ERBB2IP
- ERBIN
- HER2
- HSP90A
- HSP90AA1
- HSPC1
- HSPCA
- KIAA1225
- LAP2
- MLN19
- NEU
- NGL
|
Homo sapiens (human)
|
|
Drug-mediated inhibition of ERBB2 signaling
|
|
|
- CDC37
- CDC37A
- ERBB2
- ERBB2IP
- ERBIN
- HER2
- HSP90A
- HSP90AA1
- HSPC1
- HSPCA
- KIAA1225
- LAP2
- MLN19
- NEU
- NGL
|
Homo sapiens (human)
|
|
Resistance of ERBB2 KD mutants to tesevatinib
|
|
|
- CDC37
- CDC37A
- ERBB2
- ERBB2IP
- ERBIN
- HER2
- HSP90A
- HSP90AA1
- HSPC1
- HSPCA
- KIAA1225
- LAP2
- MLN19
- NEU
- NGL
|
Homo sapiens (human)
|
|
Drug resistance in ERBB2 TMD/JMD mutants
|
|
|
- CDC37
- CDC37A
- ERBB2
- ERBB2IP
- ERBIN
- HER2
- HSP90A
- HSP90AA1
- HSPC1
- HSPCA
- KIAA1225
- LAP2
- MLN19
- NEU
- NGL
|
Homo sapiens (human)
|
|
Resistance of ERBB2 KD mutants to trastuzumab
|
|
|
- CDC37
- CDC37A
- ERBB2
- ERBB2IP
- ERBIN
- HER2
- HSP90A
- HSP90AA1
- HSPC1
- HSPCA
- KIAA1225
- LAP2
- MLN19
- NEU
- NGL
|
Homo sapiens (human)
|
|
Resistance of ERBB2 KD mutants to afatinib
|
|
|
- CDC37
- CDC37A
- ERBB2
- ERBB2IP
- ERBIN
- HER2
- HSP90A
- HSP90AA1
- HSPC1
- HSPCA
- KIAA1225
- LAP2
- MLN19
- NEU
- NGL
|
Homo sapiens (human)
|
|
Resistance of ERBB2 KD mutants to neratinib
|
|
|
- CDC37
- CDC37A
- ERBB2
- ERBB2IP
- ERBIN
- HER2
- HSP90A
- HSP90AA1
- HSPC1
- HSPCA
- KIAA1225
- LAP2
- MLN19
- NEU
- NGL
|
Homo sapiens (human)
|
|
Resistance of ERBB2 KD mutants to osimertinib
|
|
|
- CDC37
- CDC37A
- ERBB2
- ERBB2IP
- ERBIN
- HER2
- HSP90A
- HSP90AA1
- HSPC1
- HSPCA
- KIAA1225
- LAP2
- MLN19
- NEU
- NGL
|
Homo sapiens (human)
|
|
NGF-independant TRKA activation
|
|
|
- ADCYAP1
- ADCYAP1R1
- ADORA2
- ADORA2A
- MTC
- NTRK1
- NTRK2
- TRK
- TRKA
- TRKB
|
Homo sapiens (human)
|
|
Formation of Senescence-Associated Heterochromatin Foci (SAHF)
|
|
|
- ASF1A
- CABIN1
- CAGH32
- DGCR1
- EP400
- H1-0
- H1-1
- H1-2
- H1-3
- H1-4
- H1-5
- H1F0
- H1F1
- H1F2
- H1F3
- H1F4
- H1F5
- H1FV
- HIR
- HIRA
- HIST1H1A
- HIST1H1B
- HIST1H1C
- HIST1H1D
- HIST1H1E
- HMGA1
- HMGA2
- HMGIC
- HMGIY
- KIAA0330
- KIAA1498
- KIAA1818
- LMN2
- LMNB
- LMNB1
- P53
- RB1
- TNRC12
- TP53
- TUPLE1
- UBN1
|
Homo sapiens (human)
|
|